AVE 33.3% 0.2¢ avecho biotechnology limited

Mak,The market is very sensitive to POH, troubles in the past...

  1. 1,539 Posts.
    Mak,

    The market is very sensitive to POH, troubles in the past with Management (goes without saying), No driving power to promote the science, Leadership a query to say the least.

    All bark, I like the TPM process but unfortunately so far the Co has no bite as it appears the General non informed market evaluates it.

    13c should hold - That's it! don't expect anything until later?.

    P.S - I remain loyal to the science pedigree here -but Management has always disappointed me (never thought Esra was suited and I got bagged for saying so).

    Always the Optimist?.........
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.